A differential screen for ligand-regulated genes: Identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells

Molecular and Cellular Biology

Volumn 18, Issue 4, 1998, Pages 1911-1918

  Rots, Nynke Y ^a   Liu, Min ^a,b   Anderson, Eric C ^a   Freedman, Leonard P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE ISOLATION; GENE OVEREXPRESSION; GROWTH INHIBITION; HORMONAL REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031924791     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.4.1911     Document Type: Article

References (40)

1. Abe, E., C. Miyaura, H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki, and T. Suda. 1981. Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA 78:4990-4994.
2. Ahn, J. Y., N. Tanahashi, K. Akiyama, H. Hisamatsu, C. Noda, K. Tanaka, C. H. Chung, N. Shibmara, P. J. Willy, J. D. Mott, C. A. Slaughter, and G. N. DeMartino. 1995. Primary structures of two homologous subunits of PA28, a γ-interteron-inducible protein activator of the 20S proteasome. FEBS Lett. 366:37-12.
3. Amati, B., and H. Land. 1994. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation, and death. Curr. Opin. Genet. Dev. 4:102-108.
4. 3a. Anderson, E. C., N. R. Rots, and L. P. Freedman. Unpublished data.
5. Ayer, D. E., and R. N. Eisenman. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 7:2110-2119.
6. Ayer, D. E., L. Jretzner, and D. E. Eisenman. 1993. Mad: a heterodimeric partner of Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
7. Beadling, C., K. W. Johnson, and K. A. Smith. 1993. Isolation of interleukin 2-induced immediate early genes. Proc. Natl. Acad. Sci. USA 90:2719-2723.
8. Benson, G. V., T.-H. E. Nguyen, and R. L. Maas. 1995. The expression pattern of the murine Hoxa-10 gene and the sequence recognition of its homeodomain reveal specific properties of Abdominal B-like genes. Mol. Cell. Biol. 15:1591-1601.
9. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
10. Brechot, C. 1993. Oncogenic activation of cyclin A. Curr. Opin. Genet. Dev. 3:11-18.
11. Ellisen, L. W., J. Bird, D. C. West, A. L. Soreng, T. C. Reynolds, S. D. Smith, and J. Sklar. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-661.
12. Evan, G. I., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44-49.
13. Gehring, W. J., and Y. Hiromi. 1986. Homeotic genes and the homeobox. Annu. Rev. Genet. 20:147-173.
14. Gray, C. W., C. A. Slaughter, and G. N. DeMartino. 1994. PA28 activator protein forms regulatory caps on proteasome stacked rings. J. Mol. Biol. 236:7-15.
15. Helistrom E., K. H. Robert, E. Soppi, P. O. Putkoken, and G. Gahrton. 1989. Effects of retinoic acid. 1,25-dihydroxyvitamin D3, cytosine arabinoside, and interferon α on bone marrow cells from patients with myelodysplastic syndrome. Leuk. Res. 13:113-120.
16. Honma, Y., M. Huzumi, E. Abe, K. Konno, M. Fukushima, S. Hata, Y. Nishii H. F. DeLuca, and T. Suda. 1983. 1α,25-dihydroxyvitamin D3 and 1α-hydroxyvitamin D3 prolong the survival time of mice inoculated with myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 80:201-204.
17. Howell, A. L., T. A. Satukel, C. D. Bloomfield, F. R. Davey, and E. D. Ball. 1991. High dose vitamin D for treatment of myelodysplasia: a pilot study. Br. J. Haematol. 77:30-35.
18. Kizaki, M., and H. P. Koeffler. 1992. Differentiation-inducing agents in the treatment of myelodysplastic syndromes. Semin. Oncol. 19:95-111.
19. Langston, A. W., and L. Gudas. 1994. Retinoic acid and homeobox gene regulation. Curr. Opin. Genet. Dev. 4:550-555.
20. Langston, A. W., and L. J. Gudas. 1992. Identification of a retinoic responsive enhancer 3′ of the murine gene Hox-1.6. Mech. Dev. 38:217-228.
21. Larsson, L. G., M. Pettersson, F. Oberg, K. Nillson, and B. Luscher. 1994. Expression of mad, mxi1, max, and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9:1247-1252.
22. Lawrence, H. J., and C. Largman. 1992. Homeobox genes in normal hematopoiesis and leukemia. Blood 80:2445-2453.
23. Lawrence H. J., G. Sauvageau, N. Ahmadi, A. R. Lopez, M. M. LeBeau, M. Link, K. Humphries, and C. Largman. 1995. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Exp. Hematol. 23:1160-1166.
24. Levine, M., and T. Hoey. 1988. Homeobox proteins as sequence-specific transcription factors. Cell 55:537-540.
25. 23a. Liu, M. 1996. Ph.D. thesis. Cornell University School of Medical Sciences, Ithaca, N.Y.
26. Liu, M., M.-H. Lee, M. Cohen, and L. P. Freedman. 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:142-151.
27. Lowney, P., J. Corral, K. Detmer, M. M. LeBeau, L. Deaven, H. J. Lawrence, and C. Largman. 1991. A human Hox 1 homeobox gene exhibits myeloidspecific expression of alternative transcripts in human hematopoietic cells. Nucleic Acids Res. 19:3443-3449.
28. Moore, M. A. S. 1987. Growth and maturation factors in leukemia, p. 399-445. In R. K. Oldham (ed.), Principles of cancer biotherapy. Raven Press, New York, N.Y.
29. Munker, R., A. Norman, and H. P. Koeffler. 1986. Vitamin D compounds: effect on clonal proliferation and differentiation of human myeloid cells. J. Clin. Invest. 78:474-480.
30. Nikaido, T., K. Shimada, Y. Nishida, R. S. Lee, A. B. Pardee, and Y. Nishizuka. 1989. Loss in transformed cells of cell cycle regulation of expression of nuclear protein recognized by SLE patient antisera. Exp. Cell Res. 182:284-289.
31. Nikaido, T., K. Shimada, M. Shibata, M. Hata, M. Sakamoto, Y. Takasaki, and C. Sato. 1990. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus. Exp. Immunol. 79:209-214.
32. 3. Cancer Res. 43:5862-5870.
33. Popperl, H., and M. S. Featherstone. 1993. Identification of a retinoic acid response element upstream of the murine Hox-42 homeobox gene. Mol. Cell. Biol 13:217-265.
34. Pratt, M. A. C., A. W. Langston, L. J. Gudas, and M. W. McBurney. 1993. Retinoic acid fails to induce the expression of Hox genes in differentiation-defective murine embryonal carcinoma cells carrying a mutant gene for alpha retinoic acid receptor. Development 53:105-113.
35. 31a. Rots, N. Y., and L. P. Freedman. Unpublished data.
36. Satokata, I., G. Benson, and R. Maas. 1995. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 374:460-463.
37. Shen, W.-F., K. Detmer, D. A. Morgan, C. Largman, and H. J. Lawrence. 1992. Modulation of homeobox gene expression alters the phenotype of human hematopoietic cell lines. EMBO J. 11:2445-2453.
38. Thorsteindottir, U., G. Sauvageau, M. R. Hough, W. Dragowska, P. M. Landsorp, H. J. Lawrence, C. Largman, and R. K. Humphries. 1997. Over-expression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid differentiation. Mol. Cell. Biol. 17:495-505.
39. Woodford, T. A., R. Schlegel, and A. B. Pardee. 1988. Selective isolation of newly synthesized mammalian mRNA after in vivo labelling with 4-thiouridine or 6-thiouridine. Anal. Biochem. 171:166-172.
40. Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.